CARLSBAD, Calif – GenomeWeb, a popular scientific news outlet, posted an article on Chromacode’s technology and its use in developing multiplex infectious disease assays as well as highlighting the opportunity for future use in the oncology and genetics markets. The article discusses the pending pipeline, key advantages and the Company’s unique approach, which doesn’t require a new instrument.
The article shares with readers ChromaCode’s next major public event taking place at the upcoming AMP meeting November 1-3, 2018 San Antonio, Texas. ChromaCode will have multiple posters, workshop and a booth to launch its first product in the market targeted at Tick Born Viruses.
